Nuwellis Inc (NUWE) Stock Price, Quote & News

Company Profile

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. wa...

Industry: Medical Devices

Sector: Healthcare

Phone: 952 345 4200

Website: www.nuwellis.com

Address:

12988 Valley View Road, Eden Prairie, United States

Slinger2661 Jul. 2 at 11:10 PM

$NUWE Just let it run!!!

0 · Reply

maltdmark Jul. 2 at 10:42 PM

$NUWE 👀post-split nekkiD shorted fckng time-bomb. any whale trader only need iginite this micro-mofo and like so many others been multi-bagging $$$ this thing would be GONE💰

0 · Reply

Rickyboy06 Jul. 2 at 10:32 PM

$NUWE Let's see if this will pickup some attention and volume

0 · Reply

TATTED_KEN Jul. 2 at 10:28 PM

$FXHO next $NUWE cant say I didn’t give you a target of $20

0 · Reply

rk2_0wen Jul. 2 at 10:23 PM

$BMGL theres also $NUWE 200% short and 300k float. how can double the float be short?

0 · Reply

Mamatrader3 Jul. 2 at 10:22 PM

$FXHO low float banger - next on my radar are $GMEX $NUWE $LABT

0 · Reply

TATTED_KEN Jul. 2 at 10:20 PM

Recap. ✅ $ZCMD: $2 → $6 ✅ $RDGT: $1.49 → $2.30 ✅ $FXHO: $7 → $19 (still looking for $20) Next up: $NUWE. Mark this post. 🎯 I’m watching for a move toward $5. Now let’s see if volume shows up and the market does the rest.

0 · Reply

rk2_0wen Jul. 2 at 10:19 PM

$SDOT $NUWE just had a RS and is 200% short? 300k float. yikes…

1 · Reply

rk2_0wen Jul. 2 at 10:17 PM

$ZCMD if anyone is interested $NUWE IS 200% SHORT??? how is this possible?

0 · Reply

rk2_0wen Jul. 2 at 10:11 PM

$NUWE um how is this possible?

0 · Reply

Nuwellis Celebrates Five Years of Support of the Pediatric Cardiac Critical Care Consortium (PC⁴)

Jun 26, 2026, 8:00 AM EDT - 8 days ago

Nuwellis Proxy statement: Proxy filing

2026-06-25T23:50:12.000Z - 8 days ago

Nuwellis Inc trading halted, news pending

Jun 25, 2026, 8:30 AM EDT - 9 days ago

Nuwellis Announces Pediatric Expansion in Michigan with First Aquadex SmartFlow® Installations

Jun 24, 2026, 8:30 AM EDT - 10 days ago

Incoming Nuwellis CEO Mike McCormick Underscores Strategic Priorities for Continued Market Expansion in Pediatric Category and Revenue Generation in Letter to Shareholders

2026-06-18T12:51:14.000Z - 16 days ago

Nuwellis highlights clinical utility of its Aquadex SmartFlow system

Jun 18, 2026, 8:30 AM EDT - 16 days ago

Nuwellis Expands Critical Care Education with Aquadex Training at University of Minnesota Critical Care Cardiology Education Summit

2026-06-16T12:50:42.000Z - 18 days ago

Nuwellis CEO transition to transition out of role, Mike McCormick to succeed

Jun 16, 2026, 8:30 AM EDT - 18 days ago

Nuwellis Appoints Mike McCormick as Chief Executive Officer

2026-06-10T12:50:10.000Z - 24 days ago

Nuwellis expands collaboration with South Carolina healthcare system

Jun 10, 2026, 8:30 AM EDT - 24 days ago

Nuwellis Expands Collaboration with Major South Carolina Healthcare System to Install New Aquadex SmartFlow® Devices at One of its Children's Hospitals

Jun 8, 2026, 9:46 PM EDT - 25 days ago

Nuwellis Announces Closing of $6.0 Million Registered Public Offering

2026-06-05T12:56:35.000Z - 4 weeks ago

Nuwellis 20M share secondary priced at 30c

Jun 5, 2026, 8:30 AM EDT - 4 weeks ago

Nuwellis Announces Pricing of $6 Million Public Offering

Jun 4, 2026, 8:00 AM EDT - 4 weeks ago

Nuwellis Registration statement: Registration filing

Jun 2, 2026, 7:00 AM EDT - 4 weeks ago

Nuwellis Slides: Investor presentation

May 29, 2026, 8:00 AM EDT - 5 weeks ago

Nuwellis Registration statement: Registration filing

2026-05-22T21:15:44.000Z - 6 weeks ago

Nuwellis files to sell 4.85M shares of common stock, warrants

May 22, 2026, 8:00 AM EDT - 6 weeks ago

Nuwellis Registration statement: Registration filing

2026-05-14T14:09:24.000Z - 7 weeks ago

Nuwellis completes Aquadex SmartFlow System pre-submission meeting with the FDA

May 14, 2026, 8:30 AM EDT - 7 weeks ago

Nuwellis Announces Successful Completion of FDA Pre-Submission 510(k) Meeting to Expand Aquadex Label

May 12, 2026, 9:00 AM EDT - 7 weeks ago

Nuwellis Earnings Call Transcript: Q1 2026

May 12, 2026, 9:00 AM EDT - 7 weeks ago

Nuwellis Earnings release: Q1 2026

May 12, 2026, 9:00 AM EDT - 7 weeks ago

Nuwellis Quarterly report: Q1 2026

May 12, 2026, 8:00 AM EDT - 7 weeks ago

Nuwellis, Inc. Announces First Quarter 2026 Financial Results

May 5, 2026, 8:00 AM EDT - 2 months ago

Nuwellis, Inc. To Announce First Quarter 2026 Financial Results on May 12, 2026

Apr 29, 2026, 8:30 AM EDT - 2 months ago

Nuwellis Highlights Case Study Featuring Precision Ultrafiltration Therapy in Pediatric Cardiorenal Care at ISHLT 2026 Annual Meeting

2026-04-28T13:19:54.000Z - 2 months ago

Nuwellis gets notice of allowance from USPTO for lumen midline catheter

Apr 28, 2026, 8:30 AM EDT - 2 months ago

Nuwellis Announces Receipt of a Notice of Allowance from the U.S. Patent and Trademark Office for Innovative Dual Lumen Midline Catheter Technology

Apr 23, 2026, 8:30 AM EDT - 2 months ago

Nuwellis to Participate in the AATS 106th Annual Meeting and ERAS Cardiac Spring Retreat

Apr 21, 2026, 8:30 AM EDT - 2 months ago

Nuwellis Announces Aquadex Software Update

2026-04-16T12:51:56.000Z - 2 months ago

Nuwellis announces return of three former team members

Apr 16, 2026, 8:30 AM EDT - 2 months ago

Nuwellis Welcomes Back Three Former Team Members to Accelerate Commercial and Clinical Momentum

Apr 9, 2026, 8:30 AM EDT - 3 months ago

Nuwellis Engages CORE IR for Public Relations, Shareholder Communications, and Social Media Management Services

2026-04-07T13:45:21.000Z - 3 months ago

Nuwellis expands commercial footprint with new South Texas territory

Apr 7, 2026, 8:30 AM EDT - 3 months ago

Nuwellis Strengthens Commercial Infrastructure with New South Texas Territory

Apr 6, 2026, 8:00 AM EDT - 3 months ago

Nuwellis Proxy statement: Proxy filing

Apr 2, 2026, 8:00 AM EDT - 3 months ago

Nuwellis Proxy statement: Proxy filing

Mar 31, 2026, 8:30 AM EDT - 3 months ago

Nuwellis Pediatric Category Achieves Approximately 50% of Total U.S. Revenue in 2025, Marking Growth Milestone

2026-03-17T12:27:39.000Z - 3 months ago

Nuwellis completes acquisition of Rendiatech

Mar 17, 2026, 8:00 AM EDT - 3 months ago

Nuwellis Completes Acquisition of Rendiatech

Mar 10, 2026, 9:00 AM EDT - 4 months ago

Nuwellis Earnings Call Transcript: Q4 2025

Mar 10, 2026, 9:00 AM EDT - 4 months ago

Nuwellis Earnings release: Q4 2025

Mar 10, 2026, 9:00 AM EDT - 4 months ago

Nuwellis Annual report: Q4 2025

2026-03-10T12:21:07.000Z - 4 months ago

Nuwellis reports Q4 EPS ($1.50) vs ($18.30) last year

Mar 10, 2026, 8:15 AM EDT - 4 months ago

Nuwellis, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results

2026-03-05T13:26:40.000Z - 4 months ago

Nuwellis appoints Goldstein as Director of Clinical Strategy

Mar 5, 2026, 8:00 AM EST - 4 months ago

Nuwellis Appoints Dr. Stuart L. Goldstein as Director of Clinical Strategy to Advance Pediatric and Cardiorenal Strategy

2026-02-26T13:12:57.000Z - 4 months ago

Nuwellis appoints McDonald, Emerson to board of directors

Feb 26, 2026, 8:00 AM EST - 4 months ago

Nuwellis Appoints David A. McDonald and Martin J.

Feb 24, 2026, 8:00 AM EST - 4 months ago

Nuwellis, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026

Feb 17, 2026, 6:00 AM EST - 4 months ago

Nuwellis Slides: Investor presentation

Feb 4, 2026, 7:00 AM EST - 5 months ago

Nuwellis Registration statement: Registration Filing

2026-02-04T11:11:26.000Z - 5 months ago

Nuwellis files to sell 4.28M shares of common stock for holders

2026-01-30T13:25:28.000Z - 5 months ago

Nuwellis appoints Schultz as Chief Financial Officer

Jan 30, 2026, 8:00 AM EST - 5 months ago

Nuwellis Appoints Carisa Schultz as Chief Financial Officer

2026-01-29T21:45:37.000Z - 5 months ago

Nuwellis announces $5M private placement, warrant inducement transaction

2026-01-29T21:40:34.000Z - 5 months ago

Nuwellis to acquire Rendiatech, terms not disclosed

Jan 29, 2026, 4:36 PM EST - 5 months ago

Nuwellis Announces $5 Million Private Placement and Warrant Inducement Transaction, Priced At-The-Market

Jan 29, 2026, 4:35 PM EST - 5 months ago

Nuwellis Enters into Definitive Agreement to Acquire Rendiatech, Advancing Its Cardiorenal Portfolio Strategy

2026-01-27T14:00:45.000Z - 5 months ago

Here’s Why Nuwellis Stock (NUWE) Rocketed Today

Jan 23, 2026, 4:40 PM EST - 5 months ago

Nuwellis Announces Changes to Board of Directors

Jan 6, 2026, 8:15 AM EST - 6 months ago

Nuwellis Announces Issuance of New U.S. Patent Supporting Advanced Safety Design for Pediatric Extracorporeal Therapy

Dec 9, 2025, 8:15 AM EST - 7 months ago

Lenox Hill Hospital Study Highlights the Broad Utility of Aquadex in Managing Fluid Overload Across Critical Care Settings

Dec 4, 2025, 8:15 AM EST - 7 months ago

Nuwellis Continues Clinician-Driven Growth in Pediatric Care with a Leading Hospital in the Northeast U.S.

Nov 12, 2025, 9:00 AM EST - 8 months ago

Nuwellis Earnings Call Transcript: Q3 2025

Nov 12, 2025, 9:00 AM EST - 8 months ago

Nuwellis Quarterly report: Q3 2025

Nov 12, 2025, 9:00 AM EST - 8 months ago

Nuwellis Earnings release: Q3 2025

Nov 12, 2025, 8:15 AM EST - 8 months ago

Nuwellis Reports Third Quarter 2025 Results and Continued Operational Momentum

Nov 10, 2025, 9:00 AM EST - 8 months ago

Nuwellis Receives Notice of Allowance of a New U.S. Patent Strengthening Vivian™ Pediatric System with Advanced Clamp Safety Technology

Oct 23, 2025, 9:00 AM EDT - 9 months ago

Nuwellis, Inc. To Report Third Quarter 2025 Financial Results on November 12, 2025

Sep 30, 2025, 8:45 AM EDT - 9 months ago

Nuwellis Announces 92% Survival in Children with Acute Kidney Injury (AKI), Fluid Overload or Congenital Kidney Failure Following Treatment with Aquadex®

Sep 18, 2025, 9:00 AM EDT - 10 months ago

Nuwellis Receives New US Patent Reinforcing Vivian™ Pediatric Device Focused on Safer, More Precise Ultrafiltration

Sep 17, 2025, 10:16 AM EDT - 10 months ago

Nuwellis, Inc. Participates in a Virtual Investor “What This Means” Segment

Sep 9, 2025, 9:00 AM EDT - 10 months ago

Nuwellis' Vivian Receives $3 Million NIH Grant to Accelerate Pediatric Platform and Strengthen Fluid-Management Portfolio

Sep 4, 2025, 8:15 AM EDT - 10 months ago

Nuwellis Introduces New 24-Hour Aquadex™ Circuit to Support Hospital-Based Outpatient and Short-Term Fluid Management

Aug 21, 2025, 8:15 AM EDT - 11 months ago

Nuwellis Receives FDA 510(k) Clearance for New Dual Lumen Extended Length Catheter

Aug 19, 2025, 8:15 AM EDT - 11 months ago

Nuwellis Signs Letter of Intent to Explore Acquisition of Rendiatech Ltd., A Real-Time Fluid Monitoring Company

Aug 15, 2025, 8:15 AM EDT - 11 months ago

Nuwellis, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

Aug 14, 2025, 9:00 AM EDT - 11 months ago

Nuwellis Earnings Call Transcript: Q2 2025

Aug 14, 2025, 9:00 AM EDT - 11 months ago

Nuwellis Quarterly report: Q2 2025

Aug 14, 2025, 9:00 AM EDT - 11 months ago

Nuwellis Earnings release: Q2 2025

Aug 14, 2025, 8:15 AM EDT - 11 months ago

Nuwellis, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights

Aug 7, 2025, 8:15 AM EDT - 11 months ago

Nuwellis to Exit International Operations to Accelerate U.S. Revenue Growth and Strategic Focus

Aug 6, 2025, 8:15 AM EDT - 11 months ago

Nuwellis Postpones Second Quarter 2025 Earnings Release and Conference Call to August 14, 2025

Aug 5, 2025, 8:15 AM EDT - 11 months ago

Nuwellis Announces the First Successful Outpatient Application of the Aquadex Smartflow® System Under New CMS Code

Aug 4, 2025, 5:24 PM EDT - 11 months ago

Nuwellis Stockholders Approve All Proposals at Special Meeting

Jul 23, 2025, 8:45 AM EDT - 1 year ago

Nuwellis Participates in the Virtual Investor “What's Your Story” Summer Spotlight On-Demand Conference

Jul 23, 2025, 8:15 AM EDT - 1 year ago

Nuwellis Regains Compliance with Nasdaq Listing Requirements

Jul 22, 2025, 8:15 AM EDT - 1 year ago

Nuwellis, Inc. To Report Second Quarter 2025 Financial Results on August 12, 2025

Slinger2661 Jul. 2 at 11:10 PM

$NUWE Just let it run!!!

0 · Reply

maltdmark Jul. 2 at 10:42 PM

$NUWE 👀post-split nekkiD shorted fckng time-bomb. any whale trader only need iginite this micro-mofo and like so many others been multi-bagging $$$ this thing would be GONE💰

0 · Reply

Rickyboy06 Jul. 2 at 10:32 PM

$NUWE Let's see if this will pickup some attention and volume

0 · Reply

TATTED_KEN Jul. 2 at 10:28 PM

$FXHO next $NUWE cant say I didn’t give you a target of $20

0 · Reply

rk2_0wen Jul. 2 at 10:23 PM

$BMGL theres also $NUWE 200% short and 300k float. how can double the float be short?

0 · Reply

Mamatrader3 Jul. 2 at 10:22 PM

$FXHO low float banger - next on my radar are $GMEX $NUWE $LABT

0 · Reply

TATTED_KEN Jul. 2 at 10:20 PM

0 · Reply

rk2_0wen Jul. 2 at 10:19 PM

$SDOT $NUWE just had a RS and is 200% short? 300k float. yikes…

1 · Reply

rk2_0wen Jul. 2 at 10:17 PM

$ZCMD if anyone is interested $NUWE IS 200% SHORT??? how is this possible?

0 · Reply

rk2_0wen Jul. 2 at 10:11 PM

$NUWE um how is this possible?

0 · Reply

TATTED_KEN Jul. 2 at 9:58 PM

$LABT definitely missed that dip into the low $2S… FML. It’s all good. Whoever was behind that move, what a rug pull. Crazy price action. On the bright side, I managed to add $NUWE by hitting the ask at $3.08, $3.07, and $3.06 for 5K shares. Now we wait and let the market do its thing.

1 · Reply

Slinger2661 Jul. 2 at 9:54 PM

$NUWE Where are you getting your float count from??

0 · Reply

hmoo6y Jul. 2 at 5:57 PM

$NUWE took some why not 660k float Chart looks promising has gap up on daily Could go crazy like $JEM $SDOT

0 · Reply

StreakGeek Jul. 2 at 4:57 PM

$NUWE $NAMI nice...

0 · Reply

twixbarrtwits Jul. 2 at 4:38 PM

$NUWE out 3.12

0 · Reply

Adrennaline Jul. 2 at 1:56 PM

$NUWE about to go

0 · Reply

TATTED_KEN Jul. 2 at 1:16 PM

$LABT doubled my position under $2.20. Now we wait for volume. Over $3.50 is where I think things get interesting. $USDE what a call, from around $2 to $9. $NUWE is still on my radar. In my opinion, it’s only a matter of time before more traders find it. Everyone stay safe this long weekend, enjoy the time with family and friends, and have fun. Oorah. 🇺🇸

3 · Reply